After becoming Assistant Professor at the Southwest Medical Center in 1999, Charles B. Epstein joined the pharma industry and worked until 2008 as principal research investigator focused on transcript profiling for biomarker discovery with Sanofi-Aventis Pharmaceuticals. Back to science, he became Program Manager for Epigenomics in 2008 and, since 2014, has served as Senior Group Leader at the Broad Institute of Harvard and MIT in Cambridge (USA).
Charles B. Epstein has been responsible for coordinating The Broad’s contributions to NIH-funded epigenomics consortia (ENCODE II, ENCODE III, and NIH Roadmap Epigenomics), as well as to diverse studies of the epigenome in cancer. He has also worked closely with computational biologists to develop innovative methods to ensure data quality.
Prof. Wolff Schmiegel, M.D.
Short Biography and Medical Focus
In 1993, he became professor for internal medicine, gastroenterology, hepatology and gastroenterological oncology. Also in 1993, he was appointed Professor and Director of the Knappschaftskrankenhaus Bochum GmbH, Ruhr-Universität Bochum (Germany) and, since 2002, has served as Head of the Department of Gastroenterology / Hepatology at the Berufsgenossenschaftliches Klinikum Bergmannsheil, Ruhr-Universität Bochum (Germany).
- American Gastroenterological Association (AGA), Fellow (AGAF)
- American Society of Clinical Oncology (ASCO)
- German Society for Gastroenterology, Digestion and Metabolic Disorders (DGVS)
- German Society for Internal Medicine (DGIM)
- German Cancer Society (DKG/AIO), Presidency from 2012 to 2016
- European Society of Medical Oncology (ESMO)
- European Society of Digestive Oncology (ESDO)
- G. E. Konjetzny Award (1988)
- Dr. Martini Award (1989)
- Stiftung zur Förderung der Innovation in Wissenschaft und Forschung NRW Award (1994)
- Charles Moertel Award in Digestive Oncology (IDCA / World Gastroenterology Organization, 2007)
- Felix Burda Award (2014)